Form D — Starget Pharma Inc.
0002108969-26-000001 · filed Feb 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $22,158,515
- Reported amount sold
- $16,373,737
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Starget Pharma Inc.
- CIK
- 2108969
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2031 KINGS HIGHWAY
SHREVEPORT, LA 71103 - Phone
- 318-746-8430
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sigal Kalmanson Cusnir · Executive OfficerTzofit, L3 Find on LinkedIn ↗
-
Ronen Kalmanson · DirectorRamat Hasharon, L3 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗